More Exclusive Features

‘Open up the floodgates’: FDA approval signals further CBD investment

Federal approval for a CBD drug means more for the hemp industry than just validation that cannabidiol has medical value. It’s also expected to increase investment in pharmaceutical uses for CBD derived from either hemp or marijuana, according to business owners working on other medicines extracted from the cannabis plant. “This is going to open up […]

Read More

Rise of CBD raises concerns for marijuana executives

CBD products are often marketed as having similar health benefits to medical marijuana without the psychoactive properties – essentially all of the medicine but none of the high. That growing mainstream appeal has some cannabis business owners concerned that CBD is a threat to the THC-reliant marijuana market.

Read More